The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Control of Glycolysis through Regulation of PFK1: Old Friends and Recent Additions
Open accessAbstract
Regulation of glucose metabolism is a crucial aspect of cell physiology in normal and disease conditions. Many regulatory events are involved in determining the metabolic fate of glucose and the pathways into which it is directed. The first reaction that commits glucose to the glycolytic pathway is catalyzed by the enzyme phosphofructokinase-1 (PFK-1) and is tightly regulated. One of the most potent activators of PFK-1 is fructose 2,6 bisphosphate (F2,6BP) and its cellular levels are correlated with glycolytic flux. F2,6BP is synthesized and degraded by a family of bifunctional enzymes-the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFKFB). The interplay among F2,6BP levels, the enzymes that generate and degrade it, and PFK-1 activity has important consequences for several different aspects of cell metabolism as well as for systemic metabolic conditions. TIGAR, a recently identified F2,6 bisphosphatase (F2,6BPase), could also contribute to this complexity and participate in shaping the metabolic profile of the cell.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Self-citationEnergy metabolism in tumor cells
Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, A., & Saavedra, E. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,082
Herrero-Mendez, A., Almeida, A., Fernández, E., Maestre, C., Moncada, S., & Bolaños, J. P. (2009) · Nature Cell Biology · doi:10.1038/ncb1881 · Cited by 844
Marsin, A.-S., Bertrand†, L., Rider, M. H., Deprez, J., Beauloye, C., Vincent‡, M. F., Van den Berghe‡, G., Carling, D., & Hue, L. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00742-9 · Cited by 824
Weber, G. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703032960905 · Cited by 641
RIDER, M. H., BERTRAND, L., VERTOMMEN, D., MICHELS, P. A., ROUSSEAU, G. G., & HUE, L. (2004) · Biochemical Journal · doi:10.1042/bj20040752 · Cited by 440
Clem, B., Telang, S., Clem, A., Yalcin, A., Meier, J., Simmons, A., Rasku, M. A., Arumugam, S., Dean, W. L., Eaton, J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0482 · Cited by 432
Fructose 2,6-bisphosphate 2 years after its discovery
Hers, H. G., & Van Schaftingen, E. (1982) · Biochemical Journal · doi:10.1042/bj2060001 · Cited by 431
Enzymology of Cancer Cells: (Second of Two Parts)
Weber, G. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703102961005 · Cited by 416
Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer
Yalcin, A., Telang, S., Clem, B., & Chesney, J. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.003 · Cited by 405
Marsin, A.-S., Bouzin, C., Bertrand, L., & Hue, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205213200 · Cited by 379
Modulation of intracellular ROS levels by TIGAR controls autophagy
Bensaad, K., Cheung, E. C., & Vousden, K. H. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.242 · Cited by 360
Self-citationPFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate
Okar, D. A., Lange, A. J., Manzano, À., Navarro-Sabatè, A., Riera, L., & Bartrons, R. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01699-6 · Cited by 357
Atsumi, T., Chesney, J. A., Metz, C. N., Leng, L., Donnelly, S. C., Makita, Z., Mitchell, R., & Bucala, R. (2002) · PubMed · Cited by 323
Chesney, J., Mitchell, R., Benigni, F., Bacher, M., Spiegel, L., Al-Abed, Y., Han, J. H., Metz, C., & Bucala, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3047 · Cited by 287
Yalcin, A., Clem, B. F., Simmons, A., Lane, A., Nelson, K., Clem, A. L., Brock, E., Siow, D., Wattenberg, B., Telang, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016816 · Cited by 242
Minchenko, O., Opentanova, I., & Caro, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01179-7 · Cited by 236
Bando, H., Atsumi, T., Nishio, T., Niwa, H., Mishima, S., Shimizu, C., Yoshioka, N., Bucala, R., & Koike, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0149 · Cited by 210
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase
Telang, S., Yalcin, A., Clem, A. L., Bucala, R., Lane, A. N., Eaton, J. W., & Chesney, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209709 · Cited by 168
Almeida, A., Bolaños, J. P., & Moncada, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913668107 · Cited by 166
Leite, T. C., SILVA, D. N. N. D., Coelho, R. G., Zancan, P., & Sola‐Penna, M. (2007) · Biochemical Journal · doi:10.1042/bj20070687 · Cited by 156
Tudzarova, S., Colombo, S. L., Stoeber, K., Carcamo, S., Williams, G. H., & Moncada, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102247108 · Cited by 136
Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)
Li, H., & Jogl, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807821200 · Cited by 127
Moon, J.-S., Jin, W.-J., Kwak, J.-H., Kim, H.-J., Yun, M.-J., KIM, J.-W., Park, S. W., & Kim, K.-S. (2011) · Biochemical Journal · doi:10.1042/bj20101104 · Cited by 125
Calvo, M., Bartrons, R., Castaño, E., Perales, J. C., Navarro‐Sabaté, À., & Manzano, À. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.093 · Cited by 124
Derdák, Z., Lang, C. H., Villegas, K. A., Tong, M., Mark, N. M., de la Monte, S. M., & Wands, J. R. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.007 · Cited by 116
Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer
Won, K. Y., Lim, S., Kim, G. Y., Kim, Y. W., Han, S., Song, J. Y., & Lee, D. K. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.04.021 · Cited by 114
Glucose-Induced Exertional Fatigue in Muscle Phosphofructokinase Deficiency
Haller, R. G., & Lewis, S. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102073240603 · Cited by 106
Reversible High Affinity Inhibition of Phosphofructokinase-1 by Acyl-CoA
Jenkins, C. M., Yang, J., Sims, H. F., & Gross, R. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.203661 · Cited by 106
Huo, Y., Guo, X., Li, H., Wang, H., Zhang, W., Wang, Y., Zhou, H., Gao, Z., Telang, S., Chesney, J. A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.058446 · Cited by 91
Donthi, R. V., Ye, G., Wu, C., McClain, D. A., Lange, A. J., & Epstein, P. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405510200 · Cited by 82
Atsumi, T., Nishio, T., Niwa, H., Takeuchi, J., Bando, H., Shimizu, C., Yoshioka, N., Bucala, R., & Koike, T. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3349 · Cited by 82
p53 and TIGAR regulate cardiac myocyte energy homeostasis under hypoxic stress
Kimata, M., Matoba, S., Iwai‐Kanai, E., Nakamura, H., Hoshino, A., Nakaoka, M., Katamura, M., Okawa, Y., Mita, Y., Okigaki, M., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00250.2010 · Cited by 77
Real-Hohn, A., Zancan, P., SILVA, D. N. N. D., Martins, E. R., Salgado, L. T., Mermelstein, C., Gomes, A. M. O., & Sola‐Penna, M. (2010) · Biochimie · doi:10.1016/j.biochi.2010.01.023 · Cited by 67
García, M., Pujol, A., Ruzo, A., Riu, E., Ruberte, J., Arbós, A., Serafín, A., Albella, B., Felíu, J. E., & Bosch, F. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000615 · Cited by 66
Keßler, R., Bleichert, F., Warnke, J., & Eschrich, K. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-007-9471-7 · Cited by 62
Lui, V. W. Y., Wong, E. Y. L., Ho, K., Ng, P. K., Lau, C. P. Y., Tsui, S. K., Tsang, C.-M., Tsao, S., Cheng, S. H., Ng, M. H., et al. (2010) · Oncogene · doi:10.1038/onc.2010.490 · Cited by 58
Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts
Kole, H. K., Resnick, R. J., Van Doren, M., & Racker, E. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90084-v · Cited by 57 · cited 2×
“Reciprocally, cells transformed by oncogenes such as v-src/vfps or ras showed elevated F2,6BP as well as increased glycolytic flux (Bosca et al. 1986; Kole et al. 1991), demonstrating the”
BackgroundBoscá, L., Mojena, M., Ghysdael, J., Rousseau, G. G., & Hue, L. (1986) · Biochemical Journal · doi:10.1042/bj2360595 · Cited by 54
Mukhtar, M. H., Payne, V. A., Arden, C., Harbottle, A., Khan, S. A., Lange, A. J., & Agius, L. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00593.2007 · Cited by 40
Cited by
Everts, B., Amiel, E., Huang, S. C.-C., Smith, A. M., Chang, C.-H., Lam, W. Y., Redmann, V., Freitas, T. C., Blagih, J., van der Windt, G. J. W., et al. (2014) · Nature Immunology · doi:10.1038/ni.2833 · Cited by 1,064
Aerobic glycolysis tunes YAP/TAZ transcriptional activity
Enzo, E., Santinon, G., Pocaterra, A., Aragona, M., Bresolin, S., Forcato, M., Grifoni, D., Pession, A., Zanconato, F., Guzzo, G., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201490379 · Cited by 414
Yang, Z., Fujii, H., Mohan, S. V., Goronzy, J. J., & Weyand, C. M. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130252 · Cited by 334
Zhong, X., He, X., Wang, Y., Hu, Z., Huang, H., Zhao, S., Wei, P., & Li, D. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01358-5 · Cited by 329
Shestov, A. A., Liu, X., Ser, Z., Cluntun, A. A., Hung, Y. P., Huang, L., Kim, D., Le, A., Yellen, G., Albeck, J. G., et al. (2014) · eLife · doi:10.7554/elife.03342 · Cited by 315
Metadata
- Authors
- Mor, I., Cheung, E. C., & Vousden, K. H.
- Venue
- Cold Spring Harbor Symposia on Quantitative Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2011-01-01
- Volume
- 76
- Issue
- 0
- Pages
- 211-216
- ISSN
- 0091-7451 (ISSN-L)
- 1943-4456
- OpenAlex
- W2114104841
- Cited by
- 316
- References
- 41
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.